CSL

is an Australia-based biotechnology company that develops and commercializes novel therapeutics and vaccines for the treatment of various diseases...
Read more
CSL  Managing Director & CEO: Paul McKenzie

Managing Director & CEO

Paul McKenzie

CEO Approval Rating

76/100

Annual Revenue
$14.8B
Employees
32,000
Funding
$750M
Acquisitions
7

CSL Competitors

1Grifols
2Takeda Pharmaceutical
3Sonic Healthcare
4Baxter
5Octapharma
6Novavax
7DaVita
8Roche
9Fresenius
10Teleflex

Trending Companies